Nikos Evangelou
NUH NHS Trust · University of Nottingham · Nottingham University Hospitals NHS Trust
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nikos Evangelou as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:21 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05533905 · DECISIve - DiagnosE Using the Central veIn SIgn v1.0Nottingham University Hospitals NHS Trust · completed · Multiple Sclerosis · principal investigator
- N/ANCT05225012 · Providing Emotional Support Around the Point of Multiple Sclerosis Diagnosis: PrEliMS 2University of Nottingham · completed · Multiple Sclerosis · principal investigator
- N/ANCT04863586 · COVID-19 and Multiple Sclerosis Disease Modifying TherapiesNottingham University Hospitals NHS Trust · unknown · Covid19, Multiple Sclerosis · principal investigator
- N/ANCT04858763 · MS Relapses During COVID-19 PandemicNottingham University Hospitals NHS Trust · completed · Multiple Sclerosis, Covid19, Relapsing Remitting Multiple Sclerosis · principal investigator
- N/ANCT04544176 · COVID-19 Risk From Attending Outpatient Radiology AppointmentsNottingham University Hospitals NHS Trust · completed · Covid19 · principal investigator
- N/ANCT04354519 · The United Kingdom Multiple Sclerosis Register Covid-19 SubstudySwansea University · completed · Multiple Sclerosis, COVID-19 · principal investigator
- N/ANCT04024969 · DiagnosE Using the Central veIn SIgnNottingham University Hospitals NHS Trust · unknown · Multiple Sclerosis · principal investigator
- N/ANCT03867513 · The Role of MEG in Assessment and Diagnosis In mTBIUniversity of Nottingham · unknown · Brain Injuries, Traumatic · principal investigator
- Ph4NCT03535298 · Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMSThe Cleveland Clinic · active not recruiting · Multiple Sclerosis, Relapsing-Remitting · principal investigator
- N/ANCT02485223 · Single Test to ARrive at MS Diagnosis. Using a Single MRI Brain Scan to Help Diagnose Multiple SclerosisUniversity of Nottingham · unknown · Multiple Sclerosis · principal investigator
- N/ANCT02481882 · Baseline Cortical Haemodynamics in MSUniversity of Nottingham · unknown · Multiple Sclerosis · principal investigator
- N/ANCT01805986 · Investigation of GM Pathology Using Ultra High Field (7T) MRI ScannerUniversity of Nottingham · unknown · Multiple Sclerosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:21 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:21 UTC. The ranking covers the 200 most relevant of 9 PubMed records, and a shared surname and initials can bring in a namesake. All 9 on PubMed
- Hookworm Treatment for Relapsing Multiple Sclerosis: A Randomized Double-Blinded Placebo-Controlled Trial.JAMA Neurol · 202060 citationsRCR 3.0
- 31 citationsRCR 1.1
- Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial.BMJ Open · 201518 citationsRCR 0.6
- Self-help Acceptance and Commitment Therapy for Carers of People with Multiple Sclerosis: A Feasibility Randomised Controlled Trial.J Clin Psychol Med Settings · 202117 citationsRCR 2.0
- Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial.Mult Scler · 201916 citationsRCR 0.6
- 15 citationsRCR 4.5
- Providing Emotional Support During the Process of Multiple Sclerosis Diagnosis (PrEliMS): A Feasibility Randomised Controlled Trial.Clin Rehabil · 20244 citationsRCR 1.2